Dr. Yanin Chávarri-Guerra discusses what barriers to cancer care exist in Mexico and how the country is working to expand access to genetic testing for people with cancer.
Leona deVinne felt guilty when she learned her son had the same VHL diagnosis she has that causes a high risk of cancer. Here’s how she learned to cope.
Lea los puntos destacados iniciales de la investigación del programa científico virtual ASCO20 que se acaban de publicar. Estos incluyen estudios sobre dejar de fumar y la supervivencia al cáncer de pulmón, el tratamiento del cáncer de ovario recurrente, la evaluación geriátrica para los pacientes que están recibiendo terapia sistémica, cómo la ampliación de Medicaid afecta a la mortalidad por cáncer en EE. UU. y el uso de videoconferencias con los cuidadores a distancia.
Read early research highlights just released from the ASCO20 Virtual Scientific Program. They include studies on quitting smoking and lung cancer survival, recurrent ovarian cancer treatment, geriatric assessment for patients receiving systemic therapy, how Medicaid expansion is impacting U.S. cancer mortality, and using videoconferencing with long-distance caregivers.
Can cancer risk run in families? Two pathologists answer 4 frequently asked questions about inherited cancer.
Research from the ASCO Breakthrough global summit highlights innovations in blood tests to find cancer and using genetic markers to personalize the use of radiation therapy.
Learn how tumor marker tests can help doctors diagnose cancer and plan the best possible treatment plan for each person.
The "Your Stories" podcast series from Conquer Cancer, the ASCO Foundation, provides insight into what it’s like to conquer cancer from different viewpoints. The podcasts featured here touch on how families cope with a cancer diagnosis.
Kimberly Pena was 31 when she was diagnosed with breast cancer, the same age her mother was when she was diagnosed more than 3 decades earlier. She shares her experience with cancer, treatment, and trying to convince her family to be tested for the BRCA genetic mutation.
In this podcast interview, Dr. Allison W. Kurian talks about a recent study showing that most women with breast or ovarian cancer do not receive genetic testing.
